Early oral anti-inflammatory diet for nutritional management in patients with mild acute pancreatitis: a randomized controlled trial
In brief
Anti-inflammatory diet shortened stays and reduced readmissions in mild pancreatitis trial
In a randomized trial of 68 patients with mild acute pancreatitis, an early oral anti-inflammatory diet was linked to shorter hospital stays, fewer 30-day readmissions, lower inflammation, and smaller losses in nutritional measures than conventional dietary management. Loose stools were also less common, while abdominal pain and bloating were similar. The small, single-center trial did not report the size of these benefits.
- Journal
- Food & function (Q1)
- Published
- 10 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Hairong Lin, Hong Li, Huan Ma, Yujun Luo, Jianbo Yang, Xue Yang, et al.
- PMID
- 43006140
- DOI
- 10.1039/d6fo02770a
Why clinicians should know about it
- Picked for Gastroenterology (top studies of the week, 15 November 2026): Randomized trial of early dietary management in acute pancreatitis
Abstract
Acute pancreatitis is a hypermetabolic inflammatory disease prone to negative nitrogen balance, making nutritional management critical. Early oral feeding in mild cases can reduce dysbiosis, inflammation, and nutritional risks, but specific guidance is lacking. Anti-inflammatory diets reduce inflammation and modulate gut microbiota, yet have not been applied in mild acute pancreatitis. Therefore, this study aims to develop an early oral anti-inflammatory diet protocol for mild cases and evaluate its safety and efficacy. A randomized controlled trial was conducted. Patients with acute pancreatitis hospitalized in the Department of Gastroenterology of a tertiary hospital in Mianyang, Sichuan Province from December 2024 to December 2025 were enrolled and randomly assigned to an intervention group or a control group (n = 34 each). The control group received conventional dietary management, while the intervention group received an anti-inflammatory diet protocol. Generalized estimating equation models and repeated-measures ANOVA were used to assess safety and efficacy. Safety: No significant differences were observed between groups in the incidence of abdominal pain or bloating; however, the intervention group had a significantly lower incidence of loose stools (P = 0.007). Serum lipase, amylase, and triglycerides showed no significant between-group differences (P = 0.793, 0.665, and 0.314, respectively). Efficacy: The intervention group had lower 2-hour postprandial glucose (P = 0.045). High-sensitivity C-reactive protein was significantly lower in the intervention group (P = 0.013). The intervention group showed smaller decreases in albumin, body weight, and prealbumin (all P < 0.05), as well as smaller changes in muscle mass and fat mass. Mean hospital stay was significantly shorter in the intervention group (P = 0.016), and the 30-day readmission rate was significantly lower (P = 0.039). Significant differences in microbial species were found between the two groups, with enrichment of beneficial bacteria such as Veillonella and Bifidobacterium in the intervention group, and enrichment of Corynebacteriaceae in the control group. The early oral anti-inflammatory diet protocol is safe and effective for patients with mild acute pancreatitis and can serve as a reference for clinical nutritional management. It effectively reduces inflammation, improves nutritional reserves, and helps maintain gut microbiota stability. Furthermore, it lowers the 30-day readmission rate, shortens hospital stay, and reduces the economic burden on patients. Chinese Clinical Trial Registry ChiCTR2400094056 (https://www.chictr.org.cn/index.html).
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.